Professional Documents
Culture Documents
--------------------------------------------------------------------------------
Table of Contents
Introduction
Technical Aspects/Philosophy
Primer Design
Reaction Conditions
"Mechanics" of the Reaction
Methodology
A. Cell and Tissues.
1. Cultured Cells: Infection and Preparation.
2. Tissues: Pulmonary infection and preparation.
B. In Situ Amplification
1. Cultured Cells in Suspension.
2. Tissues on Slides.
C. Detection of Amplified DNA by in situ Hybridization
1. Solution amplification.
2. Tissue Sections.
References
--------------------------------------------------------------------------------
Introduction
The diversity of pathogenesis presents a spectrum of challenges to the
researcher, who is required to utilize a wide variety of tools and techniques,
including those of a histological, immunological and molecular nature. Within the
larger context of pathogenesis, the determination of the mechanism of viral
latency and slowly progressing viral diseases is particularly provoking. Here, the
molecules involved in the initiation and progression of disease may be present in
vanishingly small quantities in a minor population of cells or tissues, and the
dynamics of expression of functions within the cells will vary over time. In many of
these slowly-evolving diseases, requiring months or years to manifest clinically, it
has been shown that, with respect to viral genetic information, the majority of the
infected or affected population is in a transcriptionally inactive state, and at a
level of one genome [or gene] per host cell.
An example of one of the most difficult issues in viral pathogenesis today is that
presented by the lentiviruses, members of the "complex" subgroup of the
retroviruses, which includes HIV, the causative agent of AIDS in humans, and the
prototype for the class, visna-maedi, which causes neurological and pulmonary
disease in sheep. Upon infection with these agents, the provirus frequently
integrates into the host genome and establishes a persistent infection, whereby
the infected cells are characterized by, among other things, a transcriptionally-
quiescent state with respect to the viral antigens, which allows the infected cells
to escape host immune surveillance [the Trojan horse mechanism]. It is this state
which is pathogenically and epidemiologically most interesting, and potentially
the most lethal, since these cells provide a reservoir for the future release of
active virus. It is these latently infected individual cells, then, which need to be
discovered and enumerated in order to gain some insight into the essence and
the extent of the infection, the progression to expression and, eminently, the
control of this progression.
The techniques of nucleic acid hybridization and the polymerase chain reaction
[PCR] have been used extensively to investigate these issues of pathogenesis.
While powerful in their own right, these techniques are essentially population
studies: nucleic acids are isolated from a population of cells which contains either
a sufficient number of molecules to detect directly by standard hybridization
techniques, or, when a subpopulation contains as little as a single copy of nucleic
acid, that molecule amplified by the PCR, and detected after amplification. In situ
hybridization applies and extrapolates the technology of nucleic acid hybridization
to the single cell level, and, in combination with the artistry of cytochemistry and
immunocytochemistry, permits the maintenance of morphology and the
identification of cellular markers to be maintained and identified, allows the
localization of sequences to specific cells within populations, such as tissues and
blood samples. However, with in situ, the technology is limited primarily to the
detection of non-genomic material [e.g., RNA], reiterated genes or multiple
genomes, since the limits of detection in most situations are several copies of the
target nucleic acid per cell. In part due to these copy number considerations,
hybridizations for RNA are considerably more sensitive than for DNA detection. In
addition, other factors which affect the sensitivity of the sensitivity of the
technique toward RNA targets are the strandedness of the target molecule and
the lack of a complementary sequence proximal to the target sequences, which
kinetic theory would predict to be a preferential substrate for annealing. Other
techniques, specifically the reverse transcriptase-catalyzed in situ transcription,
have been used as well to detect RNAs which occur at relatively high copy
number. The single-copy problem proffered by the slow disease agents referred to
above, however, is beyond the realm of repeatable reality with conventional in
situ techniques.
Since the viral nucleic acid within these infected cells is below the level of routine
detection, the application of amplification technologies, of which the PCR is the
most logical choice due to its exquisite sensitivity, is essential. Clearly, the
solution-phase corollary of this problem, namely the amplification and detection of
DNA purified from a single cell, either as an individual cell or within a population
of dissimilar cells, has been resolved [see Chapter xy]. For the histological
identification of that cell within a population, such as in a tissue section or within
a blood sample, the problem becomes more complex. In addition to the standard
reaction components, consisting of enzyme, target DNA, substrate and primers,
which must be optimized in addition to varying cofactors [Mg, primer-template
ratios, etc.], one must consider other variables and potential problems, all of
which have direct consequences in the success of this technique. The importance
of the preservation of morphology and antigens of cells and tissues limits the
choice of fixation methods; these procedures are crucial to the detection of
sequences generally in in situ hybridization, and are even more so when
considering the PCR in situ. The modified cellular milieu, maintained as a
consequence of the fixation procedure, dramatically affects the efficiency of
amplification, as it introduces potential interference from protein contaminants
and cross-linking of nucleic acids and proteins. This is compounded by the general
reduction of signal that occurs in solid-phase systems. The diffusion of reaction
components into the cells likely also proceeds at a lower rate than in solution.
Finally, the amplified product DNA must be retained within the permeabilized cell
for the detection by radiolabelled probes; this necessitates a relatively large size
for the designed product DNA, which is contrary to the relatively low efficiency for
the in situ amplification reaction. All of these considerations amplify the overall
problem of detecting PCR-generated sequences within a morphologically-
identifiable cell, in addition to amplifying the sequences.
Technical Aspects/Philosophy
The techniques described in this chapter apply the PCR in the context of in situ
identification, and have been developed using the ovine lentivirus, visna-maedi,
as a model system. The details of in situ hybridization have been previously
described in detail[], and are consistent with established standards. The
amplification technique described here is applicable to cultured cells, both
adherent and non-adherent, which have been released from the growth support
and fixed in solution, as well as to cultured cells and tissues that have been fixed,
embedded, sectioned, and attached to slides; differences in strategies for the two
types of preparations will be discussed. The reaction conditions are detailed at the
end of the discussion.
Primer Design
In general, the PCR requires the critical design of a primer set. For in situ PCR, the
special considerations alluded to in the previous section make this step even more
crucial. The relatively small size of the amplification product frequently chosen for
the PCR [200-500 bp] is within the size class of molecules frequently used as
probes for in situ hybridization; that is, the diffusion characteristics of this size
class of nucleic acid is such that it passes with facility through permeabilized cell
membrane, and this diffusion is very likely enhanced in the PCR by the elevated
temperatures developed during the course of the reaction. We have demonstrated
that the retention of this size material within a cell is minimal, and the size of
choice is counter-intuitive to the principles of in situ hybridizations. In addition,
the very nature of the fixed cellular material appears to substantially hamper the
efficiency of the PCR, making the choice of a pair of primers sufficiently spaced so
that they will successfully give rise to a product DNA which will be retained within
the cell [900-1300 bp] virtually impossible. To resolve these dilemma, we
designed a set of primer pairs whose individual reaction products were 1] small
enough [app 350 bases] for efficient amplification within the constraints of fixed
cells, and 2] whose product DNA overlaps in a complementary nature to other
primers and elongated product DNA. Thus, even the cellularly-impeded reactions
should be able to give rise to a product or product network of such a size as that
described above for cellular retention. In the visna-maedi model, nine primers,
(five [+]- and four [-]-sense), each 20 nucleotides in length, are used to represent
approximately 1300 bp of contiguous sequence information from the relatively
conserved 5'-terminus of the viral genome. In addition, no two [+] and [-] primers
share identical or complimentary sequence information, and in fact are slightly
offset [approximately 20 bases], so that the primers must elongate in order to pair
with adjacent primer sets in successive cycles. As with the design of sequencing
primers, these primers are chosen from highly conserved sequences [when that
information is available], and tested for similarity to both strands of sequence
information represented by the complete GenBank Nucelotide Sequence
Database, using both pattern-matching and similarity programs; any primer
having significant similarity in the 3'-terminal 6-10 nucleotides to any gene that
may potentially be present [i.e., any ovine gene or any potentially homologous
structure in other species] in the sample is rejected. Inverted repeats, and the
consequent potential to form hairpins, are also tested for, using stem and loop
designations which would have an extremely low probability of existing under the
conditions utilized in the amplification reaction [stems, four base pairs; loops, two
nucleotides]; again, failed sequences are generally rejected. In addition, the
primers are so designed as to incorporate, to the extent feasible, the criteria of
Sninsky and Whoever.
In the overall reaction scheme, any [+] / [-] primer pair must be capable of
producing an appropriate product in a standard liquid-phase PCR with purified
template. While this test is not a general part of the protocol, it should be
considered if problems are encountered in the amplification in situ. These primer
sets, however, cannot be optimized individually, since they must exist in the
context of the multiple-primer reaction; primer pairs which cannot be used in the
standardized conditions must be re-designed
Reaction Conditions
During the initial cycles of the reaction, the stoichiometry of the nucleic acid
components are such that the reaction must be primer-driven. However, as the
reaction proceeds, it is likely that the PCR product, spanning some fraction less
than the complete target sequence, and which has not diffused from the cell,
begins to function as a target for further amplification, as well as a primer for
further elongation. Thus, it is this accumulation of sequences elongated in
multiple reactions which is retained by the fixed cell and acts as the target for the
radiolabeled probe in the detection phase.
Due to the complex physical architecture within the fixed cell, which may impede
both the efficiency of the polymerase, as well as diffusion and annealing,
elongation times are substantially longer than those for liquid conditions. In our
hands, the optimum signal is produced with a 15 minute elongation.
Methodology
Two visna-maedi model systems are described here: 1] a tissue culture system, in
which infection is efficient and productive, and viral DNA is abundant; and 2] an
animal model system, in which productively-infected cells are rare and viral DNA
in most infected cells is at levels consistent with other natural-host retroviral
infections. Both systems have been described previously and are well
characterized.
B. In Situ Amplification
1. Cultured Cells in Suspension.
Immediately prior to amplification, and for each reaction, a 2x106 cell aliquot was
pelleted from the storage solution at low speed, the ethanol removed, and the
cells hydrated in PBS-CMF for at least 20 minutes at ambient temperature. The
cells were pelleted at low speed, the initial hydration media removed and
replaced with 100-400 ul of PBS-CMF per aliquot. Each aliquot was placed in a 0.5
ml microcentrifuge tube, spun at 1600xg for five minutes and the supernate
removed. The cells were resuspended in 100 ul of PCR reaction mixture [200 uM
dNTP's, 0.1 uM primers, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2 and
0.01% gelatin]. The PCR was performed in a Perkin-Elmer Cetus Thermal Cycler,
with an initial denaturation at 94°C for 10 minutes, after which time 2.5 units Taq
polymerase [Perkin-Elmer Cetus] was added, as was a 50-100 ul mineral oil
overlay. 25 cycles of amplification were performed [denaturation, 2 minutes,
94°C; annealing, two minutes, 42 °C; extension, 15 minutes, 72°C]. After the
addition of fresh polymerase, an additional 25 cycles were performed in identical
fashion.
2. Tissues on Slides.
Deparaffinized tissue sections were overlaid with standard PCR cocktail (20-40µl,
depending on the size of the section) containing 1 µM of the multiple primer set.
The reaction mixture also contained 10mM Tris-HCl, pH 8.3, 50mM KCl, 1.5 mM
MgCl2, 0.01% gelatin, 200mM deoxynucleoside triphosphates and 5% (v/v) taq
polymerase at 5 U/ml. After covering the sections with a coverslip, the slides were
placed in heat sealable plastic pouches (4x6" x 2 mils). 5-6 ml of mineral oil was
layered over the slides, the bags were compressed to remove most of the air and
the tops were heat sealed. A slide to which a thermal sensor had been attached
by the manufacturer was similarly sealed in an oil-filled bag and the sensor and
slides with tissue sections were placed in a rack in a Bios Oven Thermal Cycler.
After 25 cycles (92°C denaturation for two minutes; 42°C annealing for two
minutes; 72°C extension for 15 minutes), the slides were removed from the bags
and washed twice [five minutes each] in CHCl3 (twice, 5 minutes each) to remove
residual oil. Each slide was taken from the CHCl3 and, as soon as the CHCl3 had
volatilized, the slips were removed with the tip of a scalpel and forceps. Fresh PCR
mixture, taq polymerase and coverslip were added prior to placing the slides back
in the oil-filled plastic bags for an additional 25 cycles. Oil was again removed in
CHCl3 and the sections were washed twice in phosphate-buffered saline (5
minutes each) and dehydrated in graded alcohols.
2. Tissue Sections.
After pretreatments with ribonucleases, postfixation in paraformaldehyde, and
denaturation in formamide as described, sections were hybridized for 12-16 hours
to a gel-purified fragment of cloned visna virus DNA corresponding to the
amplified segment, labeled with [125I] dCTP by nick translation (17) to specific
activities of 5-10 x10 8 dpm/µg (1-3 x10 6 dpm per section); or to an HIV-specific
probe labeled similarly to comparable specific activities (10). After washing for 12-
16 hours to remove unhybridized probe, the sections were dehydrated in graded
alcohols containing 0.3 mM NH4 acetate, coated with nuclear track emulsion
(Kodak NTB-2), exposed at 4°C, developed and stained with H & E. Detection and
quantitation of visna virus RNA by in situ hybridization in tissue sections followed
previous descriptions (7, 8).
125I-labelled Probes. Virus and region-specific probes were prepared by nick
translation of cloned viral DNA using 125I dCTP as precursor; or by using the PCR,
specific primer sets, at 1 µM, and 125I-dCTP as a precursor, as described by
a reaction mixture described above but lacking dCTP was added 1 µl containing 2
ng of bacteriophage λDNA as carrier and 1 ng of cloned visna DNA (9) (10 kb
genome) in pBR 322 which had been linearized with ClaI. The reaction mix was
used to redissolve 0.5 mCi of lyophilized 125I-dCTP (2200 Ci/mmol) to give a final
concentration of about 10 µM. The DNA was denatured, enzyme was added and
the PCR was carried out as follows: 94°C x 1 minute; annealing at 50°C x 2
minutes; extension at 72°C x 3 minutes. After 50 cycles, the reaction mix was
removed. The products were separated by gel filtration chromatography on
Sephadex G50 and concentrated by precipitation with ethanol and carrier RNA.
The final probe products had specific activities of 3.7 x 109 dpm per µg and were
reduced to about 150-300 bp in length as a consequence of radiolysis.
References
References pnas